1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Rise in Expenditure

        4.1.2. Increased Per Capita Expenditure

    4.2. Forecast Factors – Relevance & Impact

        4.2.1. Product in Pipeline

        4.2.2. Regulatory Scenario

        4.2.3. Mergers and Acquisitions

        4.2.4. Collaborative Agreements

        4.2.5. Value Chain

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

    4.4. COVID19 Crisis Analysis

        4.4.1. Current COVID19 Statistics and Probable Future Impact

        4.4.2. Current GDP Projection and Probable Impact

        4.4.3. Current Economic Projection as Compared to 2008 Economic analysis

        4.4.4. COVID19 and Impact Analysis

            4.4.4.1. Revenue By Therapy

            4.4.4.2. Revenue By Cancer Type

            4.4.4.3. Revenue By Mode of Administration

            4.4.4.4. Revenue By Animal Type

            4.4.4.5. Revenue By Distribution Channel

            4.4.4.6. Revenue By Country

        4.4.5. 2020 Market Scenario

        4.4.6. Quarter by Quarter Forecast

        4.4.7. Projected Recovery Quarter

        4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact

5. Market Context

    5.1. Adoption and Usage Analysis

    5.2. Market Evolution

    5.3. Product Vs Cancer Type Matrix

    5.4. Regulatory Scenario

    5.5. Parent Market Analysis

    5.6. Key Promotional Strategies by Market Players

6. Global Market – Pricing Analysis

    6.1. Regional Pricing Analysis By Therapy

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022

    7.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Therapy, 2018 to 2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy, 2023 to 2033

        8.3.1. Radiology

        8.3.2. Chemotherapy

        8.3.3. Combination Therapy

        8.3.4. Immunotherapy

        8.3.5. Targeted Therapy

    8.4. Market Attractiveness Analysis By Therapy

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Mode of Administration

    9.1. Introduction / Key Findings Nature Size, 2018 to 2022

    9.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Administration, 2023 to 2033

        9.2.1. Oral

        9.2.2. Intravenous

    9.3. Market Attractiveness Analysis By Mode of Administration

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Cancer Type

    10.1. Introduction / Key Findings Cancer Type Size, 2018 to 2022

    10.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cancer Type, 2023 to 2033

        10.2.1. Lymphoma

        10.2.2. Mast Cells

        10.2.3. Mammary & Squamous Cells

    10.3. Market Attractiveness Analysis By Cancer Type

11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Animal Type

    11.1. Introduction / Key Findings Size, 2018 to 2022

    11.2. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal Type, 2023 to 2033

        11.2.1. Canine

        11.2.2. Feline

    11.3. Market Attractiveness Analysis By Animal Type

12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2018 to 2022

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023 to 2033

        12.3.1. Hospital Pharmacies

        12.3.2. Government Agencies

        12.3.3. Retail Pharmacies

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 to 2022

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 to 2033

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. United States

            14.3.1.2. Canada

        14.3.2. By Therapy

        14.3.3. By Nature

        14.3.4. By Cancer Type

        14.3.5. By Animal Type

        14.3.6. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Market Trends

    14.6. Key Market Participants – Intensity Mapping

    14.7. Drivers and Restraints – Impact Analysis

15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. United Kingdom

            15.3.1.5. Spain

            15.3.1.6. Rest of Europe

        15.3.2. By Therapy

        15.3.3. By Nature

        15.3.4. By Cancer Type

        15.3.5. By Animal Type

        15.3.6. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Market Trends

    15.6. Key Market Participants – Intensity Mapping

    15.7. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. GCC Countries

            16.3.1.2. South Africa

            16.3.1.3. Rest of Middle East and Africa

        16.3.2. By Therapy

        16.3.3. By Nature

        16.3.4. By Cancer Type

        16.3.5. By Animal Type

        16.3.6. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Market Trends

    16.6. Key Market Participants – Intensity Mapping

    16.7. Drivers and Restraints – Impact Analysis

17. Rest of the World Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Therapy

        17.3.2. By Mode of Administration

        17.3.3. By Cancer Type

        17.3.4. By Animal Type

        17.3.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Market Trends

    17.6. Key Market Participants – Intensity Mapping

    17.7. Drivers and Restraints – Impact Analysis

18. Key and Emerging Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. United States Market Analysis

        18.2.1. By Therapy

        18.2.2. By Mode of Administration

        18.2.3. By Cancer Type

        18.2.4. By Animal Type

        18.2.5. By Distribution Channel

    18.3. Canada Market Analysis

        18.3.1. By Therapy

        18.3.2. By Mode of Administration

        18.3.3. By Cancer Type

        18.3.4. By Animal Type

        18.3.5. By Distribution Channel

    18.4. United Kingdom Market Analysis

        18.4.1. By Therapy

        18.4.2. By Mode of Administration

        18.4.3. By Cancer Type

        18.4.4. By Animal Type

        18.4.5. By Distribution Channel

    18.5. Germany Market Analysis

        18.5.1. By Therapy

        18.5.2. By Mode of Administration

        18.5.3. By Cancer Type

        18.5.4. By Animal Type

        18.5.5. By Distribution Channel

    18.6. France Market Analysis

        18.6.1. By Therapy

        18.6.2. By Mode of Administration

        18.6.3. By Cancer Type

        18.6.4. By Animal Type

        18.6.5. By Distribution Channel

    18.7. Italy Market Analysis

        18.7.1. By Therapy

        18.7.2. By Mode of Administration

        18.7.3. By Cancer Type

        18.7.4. By Animal Type

        18.7.5. By Distribution Channel

    18.8. Spain Market Analysis

        18.8.1. By Therapy

        18.8.2. By Mode of Administration

        18.8.3. By Cancer Type

        18.8.4. By Animal Type

        18.8.5. By Distribution Channel

        18.8.6. By Distribution Channel

    18.9. GCC Countries Market Analysis

        18.9.1. By Therapy

        18.9.2. By Mode of Administration

        18.9.3. By Cancer Type

        18.9.4. By Animal Type

        18.9.5. By Distribution Channel

    18.10.  South Africa Market Analysis

        18.10.1. By Therapy

        18.10.2. By Mode of Administration

        18.10.3. By Cancer Type

        18.10.4. By Animal Type

        18.10.5. By Distribution Channel

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product foot print by Players

        19.4.3. Channel Foot Print by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Elanco

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Analyst Commentary

            20.3.1.4. Key Financials

            20.3.1.5. Recent Developments

            20.3.1.6. Sales Footprint

            20.3.1.7. Strategy Overview

                20.3.1.7.1. Marketing Strategy

                20.3.1.7.2. Product Strategy

                20.3.1.7.3. Channel Strategy

        20.3.2. Morphogenesis

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Analyst Commentary

            20.3.2.4. Key Financials

            20.3.2.5. Recent Developments

            20.3.2.6. Sales Footprint

            20.3.2.7. Strategy Overview

                20.3.2.7.1. Marketing Strategy

                20.3.2.7.2. Product Strategy

                20.3.2.7.3. Channel Strategy

        20.3.3. Accuray Incorporated

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Analyst Commentary

            20.3.3.4. Key Financials

            20.3.3.5. Recent Developments

            20.3.3.6. Sales Footprint

            20.3.3.7. Strategy Overview

                20.3.3.7.1. Marketing Strategy

                20.3.3.7.2. Product Strategy

                20.3.3.7.3. Channel Strategy

        20.3.4. Regeneus Ltd.

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Analyst Commentary

            20.3.4.4. Key Financials

            20.3.4.5. Recent Developments

            20.3.4.6. Sales Footprint

            20.3.4.7. Strategy Overview

                20.3.4.7.1. Marketing Strategy

                20.3.4.7.2. Product Strategy

                20.3.4.7.3. Channel Strategy

        20.3.5. PetCure Oncology

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Analyst Commentary

            20.3.5.4. Key Financials

            20.3.5.5. Recent Developments

            20.3.5.6. Sales Footprint

            20.3.5.7. Strategy Overview

                20.3.5.7.1. Marketing Strategy

                20.3.5.7.2. Product Strategy

                20.3.5.7.3. Channel Strategy

        20.3.6. Zoetis

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Analyst Commentary

            20.3.6.4. Key Financials

            20.3.6.5. Recent Developments

            20.3.6.6. Sales Footprint

            20.3.6.7. Strategy Overview

                20.3.6.7.1. Marketing Strategy

                20.3.6.7.2. Product Strategy

                20.3.6.7.3. Channel Strategy

        20.3.7. Karyopharm

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Analyst Commentary

            20.3.7.4. Key Financials

            20.3.7.5. Recent Developments

            20.3.7.6. Sales Footprint

            20.3.7.7. Strategy Overview

                20.3.7.7.1. Marketing Strategy

                20.3.7.7.2. Product Strategy

                20.3.7.7.3. Channel Strategy

        20.3.8. Varian Medical Systems, Inc.

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Analyst Commentary

            20.3.8.4. Key Financials

            20.3.8.5. Recent Developments

            20.3.8.6. Sales Footprint

            20.3.8.7. Strategy Overview

                20.3.8.7.1. Marketing Strategy

                20.3.8.7.2. Product Strategy

                20.3.8.7.3. Channel Strategy

        20.3.9. OHC (One Health Company)

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Analyst Commentary

            20.3.9.4. Key Financials

            20.3.9.5. Recent Developments

            20.3.9.6. Sales Footprint

            20.3.9.7. Strategy Overview

                20.3.9.7.1. Marketing Strategy

                20.3.9.7.2. Product Strategy

                20.3.9.7.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

Table 01: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

Table 02: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Administration

Table 03: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Cancer Type

Table 04: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

Table 05: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 06: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type Age Group

Table 07: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

Table 08: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 09: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

Table 10: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Cancer Type

Table 11: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Administration

Table 12: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

Table 13: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 14: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 15: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

Table 16: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Cancer Type

Table 17: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Administration

Table 18: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

Table 19: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 20: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

Table 21: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

Table 22: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Cancer Type

Table 23: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Administration

Table 24: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

Table 25: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

Table 26: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapy

Table 27: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Cancer Type

Table 28: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Administration

Table 29: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

Table 30: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer